MYX — Mayne Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Mayne Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	C2022 June 30th	2023 June 30th	C2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	—	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	96.7	220	149	100	80
Net Total Accounts Receivable
Net Total Receivables	282	210	208	182	176
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	512	554	461	353	339
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	226	51.5	53.3	58.9	55.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,288	1,247	1,143	1,015	909
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	629	311	346	261	260
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	742	613	689	644	519
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	546	634	454	370	391
Total Liabilities & Shareholders' Equity	1,288	1,247	1,143	1,015	909
Total Common Shares Outstanding